About
BTNX Inc. is a biotechnology company based in Ontario, Canada, founded in 2000. It is recognized as a leader in rapid, point-of-care diagnostic solutions. The company focuses on the research, development, and manufacturing of advanced in-vitro diagnostic (IVD) tests for use in various healthcare settings, including laboratories, clinics, and hospitals. BTNX also develops information technology systems to manage diagnostic test results, adhering to HL7/POCT1-A2 standards. The product portfolio includes rapid diagnostic tests under the Rapid Response® brand, addressing a wide range of applications such as infectious diseases, drug screening, urinalysis, women's health, cancer screening, and more. BTNX has expanded its global presence, serving over 135 countries after obtaining ISO 13485 certification and CE approval. During the COVID-19 pandemic, the company became a key supplier of rapid test kits in Canada, emphasizing compliance with health standards and transparency regarding test accuracy. BTNX's customers include healthcare providers, laboratories, and distributors worldwide. The company is committed to delivering innovative, cost-effective diagnostic products and technical support, fostering strong partnerships with distributors to ensure quality and competitive pricing.
Technologies
Keywords
Company Information
-
Employees 48
-
Founded 1996
-
Annual Revenue $30019000
Location
Pickering, Ontario, Canada
